F. M. Sturtevant

645 total citations
37 papers, 420 citations indexed

About

F. M. Sturtevant is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Organic Chemistry. According to data from OpenAlex, F. M. Sturtevant has authored 37 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Physiology and 4 papers in Organic Chemistry. Recurrent topics in F. M. Sturtevant's work include Hormonal Regulation and Hypertension (11 papers), Reproductive Health and Contraception (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). F. M. Sturtevant is often cited by papers focused on Hormonal Regulation and Hypertension (11 papers), Reproductive Health and Contraception (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). F. M. Sturtevant collaborates with scholars based in United States, United Kingdom and Canada. F. M. Sturtevant's co-authors include Richard A. Edgren, C. G. Van Arman, C. M. Kagawa, Victor A. Drill, Lawrence E. Scheving, John E. Pauly, F. J. Saunders, William C. Stewart, Lyle D. Calvin and C. L. Turner and has published in prestigious journals such as Nature, Science and Annals of Internal Medicine.

In The Last Decade

F. M. Sturtevant

35 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. M. Sturtevant United States	13	111	76	51	49	43	37	420
E. Bojesen Denmark	11	86 0.8×	172 2.3×	86 1.7×	28 0.6×	12 0.3×	20	483
T.P. Blaszkowski United States	9	98 0.9×	91 1.2×	44 0.9×	81 1.7×	33 0.8×	12	386
Allan D. Bass United States	12	72 0.6×	117 1.5×	96 1.9×	20 0.4×	15 0.3×	29	439
G. Schröder Sweden	8	118 1.1×	64 0.8×	62 1.2×	106 2.2×	11 0.3×	24	360
Lawrence Silver United States	16	87 0.8×	90 1.2×	165 3.2×	76 1.6×	59 1.4×	30	690
Rex D. Stith United States	12	145 1.3×	116 1.5×	107 2.1×	18 0.4×	19 0.4×	34	621
P. Vecsei Germany	11	222 2.0×	104 1.4×	33 0.6×	57 1.2×	12 0.3×	44	463
J. R. Cox United Kingdom	12	30 0.3×	75 1.0×	97 1.9×	28 0.6×	22 0.5×	22	488
Robert Gaunt United States	14	300 2.7×	103 1.4×	64 1.3×	22 0.4×	10 0.2×	29	554
George W. Kittinger United States	19	174 1.6×	141 1.9×	118 2.3×	96 2.0×	31 0.7×	40	770

Countries citing papers authored by F. M. Sturtevant

Since Specialization

Citations

This map shows the geographic impact of F. M. Sturtevant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. M. Sturtevant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. M. Sturtevant more than expected).

Fields of papers citing papers by F. M. Sturtevant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. M. Sturtevant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. M. Sturtevant. The network helps show where F. M. Sturtevant may publish in the future.

Co-authorship network of co-authors of F. M. Sturtevant

This figure shows the co-authorship network connecting the top 25 collaborators of F. M. Sturtevant. A scholar is included among the top collaborators of F. M. Sturtevant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. M. Sturtevant. F. M. Sturtevant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vesely, David L., Eugene L. Kanabrocki, Robert B. Sothern, et al.. (1990). The Circadian Rhythm of the N-Terminus and C-Terminus of the Atrial Natriuretic Factor Prohormone. Chronobiology International. 7(1). 51–57. 14 indexed citations

Sturtevant, F. M.. (1985). Aspartame—a new food ingredient reply to the critical comments of woodrow C. Monte. Journal of Environmental Science and Health Part A Environmental Science and Engineering. 20(8). 863–901. 4 indexed citations

Edgren, Richard A. & F. M. Sturtevant. (1976). Potencies of oral contraceptives. American Journal of Obstetrics and Gynecology. 125(8). 1029–1038. 55 indexed citations

Sturtevant, F. M., et al.. (1976). Chronopharmacokinetics of ethanol. Naunyn-Schmiedeberg s Archives of Pharmacology. 293(3). 203–208. 41 indexed citations

Sturtevant, F. M. & Raymond B. Wait. (1970). High-dose estrogen sequential oral contraception I. Effectiveness assessed by the life table technique. Contraception. 2(3). 187–191. 1 indexed citations

Wait, Raymond B. & F. M. Sturtevant. (1970). High-dose estrogen sequential oral contraception II. safety with regard to thromboembolism. Contraception. 2(3). 193–198. 3 indexed citations

Sturtevant, F. M., et al.. (1961). Acute toxicity of sustained-release d-amphetamine. Toxicology and Applied Pharmacology. 3(1). 80–85. 1 indexed citations

Swintosky, Joseph V. & F. M. Sturtevant. (1960). Note on the Disappearance of Pharmacologic Activity**Received March 30, 1960, from the Smith Kline and French Laboratories, Philadelphia, Pa.. Journal of the American Pharmaceutical Association (Scientific ed ). 49(10). 685–686. 3 indexed citations

Kagawa, C. M., F. M. Sturtevant, & C. G. Van Arman. (1959). PHARMACOLOGY OF A NEW STEROID THAT BLOCKS SALT ACTIVITY OF ALDOSTERONE AND DESOXYCORTICOSTERONE. Journal of Pharmacology and Experimental Therapeutics. 126(2). 123–130. 62 indexed citations

10.

Sturtevant, F. M.. (1959). PREVENTION OF ADRENAL-REGENERATION HYPERTENSION BY AN ALDOSTERONE-BLOCKER. Endocrinology. 64(2). 299–300. 9 indexed citations

11.

Sturtevant, F. M.. (1956). Studies on vascular reactivity in normotensive and metacorticoid hypertensive rats. American Heart Journal. 52(3). 410–418. 22 indexed citations

12.

Sturtevant, F. M.. (1955). THE EFFECT OF TWO STEROID ANALOGS ON ORGAN WEIGHTS OF INTACT AND HYPOPHYSECTOMIZED RATS. Endocrinology. 56(3). 256–260. 2 indexed citations

13.

Sturtevant, F. M. & Nancy F. Hansen. (1954). EFFECT OF DIURETICS ON EXPERIMENTAL HYPERTENSION IN THE RAT. Journal of Pharmacology and Experimental Therapeutics. 112(3). 312–317. 4 indexed citations

14.

Sturtevant, F. M., et al.. (1954). STUDIES ON THE ANTI-HYPERTENSIVE ACTION OF 2,3-DIARYLALKANONITRILES. Journal of Pharmacology and Experimental Therapeutics. 112(2). 176–184. 2 indexed citations

15.

Sturtevant, F. M., et al.. (1954). A SIMPLIFIED TEST FOR ANTI-DIABETIC ACTIVITY. Endocrinology. 54(5). 561–564. 1 indexed citations

16.

Sturtevant, F. M.. (1953). Effect of Androstene Derivatives on Metacorticoid Hypertension. Experimental Biology and Medicine. 84(2). 262–263. 2 indexed citations

17.

Sturtevant, F. M.. (1953). Response of Metacorticoid Hypertension to Bistrium, Apresoline, Veriloid and Serpentina. Experimental Biology and Medicine. 84(1). 101–102. 9 indexed citations

18.

Sturtevant, F. M., et al.. (1952). EFFECT OF NITROGEN MUSTARD IN ALLOXAN DIABETES. Journal of Pharmacology and Experimental Therapeutics. 106(1). 29–36. 1 indexed citations

19.

Saunders, F. J., et al.. (1952). Mechanisms of Desoxycorticosterone Action. American Journal of Physiology-Legacy Content. 170(3). 486–497. 18 indexed citations

20.

Saunders, F. J., et al.. (1952). Mechanisms of Desoxycorticosterone Action VIII. Effects of Nephrectomy. American Journal of Physiology-Legacy Content. 170(3). 477–485. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact